3 of Eli Lilly's Top Drugs Grew by Over 40% in Q2. Trulicity Wasn't One of Them.The Motley Fool • 08/17/23
Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, NovoInvestors Business Daily • 08/17/23
Prescribing Profits: 3 Stocks to Ride the Healthcare Relative StrengthZacks Investment Research • 08/14/23
Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformGlobeNewsWire • 08/10/23
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health dataCNBC • 08/09/23
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?Investors Business Daily • 08/09/23